dalteparin has been researched along with Anemia, Hemolytic, Autoimmune in 4 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Anemia, Hemolytic, Autoimmune: Acquired hemolytic anemia due to the presence of AUTOANTIBODIES which agglutinate or lyse the patient's own RED BLOOD CELLS.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Kohlert, S | 1 |
McLean, L | 1 |
Scarvelis, D | 1 |
Thompson, C | 1 |
Demir, NA | 1 |
Basturk, A | 1 |
Ural, O | 1 |
Sumer, S | 1 |
Erdogdu, B | 1 |
Kiratli, HE | 1 |
Celik, JB | 1 |
Koplay, M | 1 |
Vatansev, H | 1 |
Mannari, D | 1 |
Liu, C | 1 |
Hughes, D | 1 |
Mehta, A | 1 |
De Giorgi, A | 1 |
Giannarelli, C | 1 |
De Negri, F | 1 |
Carmassi, F | 1 |
1 review available for dalteparin and Anemia, Hemolytic, Autoimmune
Article | Year |
---|---|
A case report of severe nasal ischemia from cold agglutinin disease and a novel treatment protocol including HBOT.
Topics: Administration, Topical; Aged, 80 and over; Anemia, Hemolytic, Autoimmune; Anticoagulants; Combined | 2019 |
3 other studies available for dalteparin and Anemia, Hemolytic, Autoimmune
Article | Year |
---|---|
A case of Evans syndrome secondary to COVID-19.
Topics: Adult; Anemia, Hemolytic, Autoimmune; Anticoagulants; COVID-19; Enoxaparin; Humans; Immunoglobulins, | 2021 |
The role of heparin in alleviating complement-mediated acute intravascular haemolysis.
Topics: 3' Untranslated Regions; Acute Disease; Adult; Anemia, Hemolytic, Autoimmune; Azathioprine; Combined | 2008 |
Thromboprophylaxis with reviparin in a patient with acquired hemophilia.
Topics: Aged; Anemia, Hemolytic, Autoimmune; Autoantibodies; Carcinoma, Renal Cell; Factor VIII; Hemophilia | 2005 |